Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Huahao Zhongtian is a synthetic biology-driven company with one commercialized oncology product and a pipeline of 19 projects. Its core platforms leverage microbial metabolites for innovative anti-tumor drugs. The company’s lead commercial product is an injection for oncology indications. Clinical results include increasing sales of its core injectable product and ongoing development of multiple candidates targeting various mechanisms in cancer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chengdu Huahao Zhongtian Biological.